Study of Oral medicine in Patients from 1 Years to Less Than 18 Years Old.
Phase 3
- Conditions
- Health Condition 1: M048- Other autoinflammatory syndromes
- Registration Number
- CTRI/2021/04/032948
- Lead Sponsor
- Eli Lilly and Company India Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Participants must have completed a previous study of baricitinib for the treatment of JIA.
Exclusion Criteria
Participants must not have had a permanent discontinuation of baricitinib in the prior study.
Participants must have not developed an allergy to baricitinib.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method